Adjuvant actions of polyclonal lymphocyte activators. III. Two distinct types of T-initiating adjuvant action demonstrated under different experimental conditions.
D000276:Adjuvants, Immunologic; D000818:Animals; D000917:Antibody Formation; D000942:Antigens, Bacterial; D001500:BCG Vaccine / Q000276:immunology; D003208:Concanavalin A / Q000494:pharmacology*; D004926:Escherichia coli / Q000276:immunology; D007114:Immunization; D007711:Klebsiella pneumoniae / Q000276:immunology; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008211:Lymphocyte Cooperation; D051379:Mice; D011072:Poly U / Q000494:pharmacology*; D011135:Polysaccharides, Bacterial / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000276:immunology
D000276:Adjuvants, Immunologic; D000942:Antigens, Bacterial; D001500:BCG Vaccine; D008070:Lipopolysaccharides; D011135:Polysaccharides, Bacterial; D003208:Concanavalin A; D011072:Poly U